| Affiliation: | 1. INSERM, U844, Site Saint Eloi - Bâtiment INM - 80 rue Augustin Fliche, University of Montpellier I, Montpellier, F-34090, France;2. Veterans Affairs Medical Center, Vanderbilt University School of Medicine, Nashville, Tennessee, USA;3. Department of Cancer Biology, Vanderbilt University School of Medicine, Nashville, Tennessee, USA;1. Univ. Paris-Sud, Laboratoire “Cytokines, Chemokines and Immunopathology”, UMR_S996, 32, rue des Carnets, Clamart F-92140, France;2. INSERM, Univ. Paris-Sud, Laboratory of Excellence in Research on Medication and Innovative Therapeutics (LERMIT), Clamart F-92140, France;1. Department of Infection and Immunity, Luxembourg Institute of Health, 29 rue Henri Koch, L-4354 Esch-sur-Alzette, Luxembourg;2. Laboratory of Molecular Pharmacology, GIGA-Molecular Biology of Diseases, GIGA B34, University of Liège, 11 Allée de l’Hôpital, B-4000 Liège, Belgium;3. Laboratory of Virology and Immunology, GIGA-Infammation, Infection & Immunity, GIGA B34, University of Liège, 11 Allée de l’Hôpital, B-4000 Liège, Belgium;1. Laboratory of Cell Death and Cancer Therapy, Department of Molecular Biomedicine, Centro de Investigaciones Biológicas, Consejo Superior de Investigaciones Científicas (CSIC), Calle Ramiro de Maeztu 9, E-28040 Madrid, Spain |
